Clinical Trial Update: Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of panitumumab with cisplatin and pelvic radiation therapy for stage IB–III cervical cancer. The study status is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Panitumumab (panitumumab)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN